IL-33/ST2信号通路在慢性鼻窦炎伴鼻息肉中的作用研究进展
Research Progress on the Role of IL-33/ST2 Signaling Pathway in Chronic Rhinosinusitis with Nasal Polyps
DOI: 10.12677/ACM.2022.1291243, PDF,   
作者: 李晨瑜：青海大学研究生院，青海 西宁；袁 芳：青海省人民医院耳鼻喉科，青海 西宁
关键词: IL-33/ST2信号通路；细胞因子；慢性鼻窦炎；鼻息肉；IL-33/ST2 Signaling Pathway； Cytokines； Chronic Rhinosinusitis； Nasal Polyps
摘要: 白细胞介素-33 (interleukin 33, IL-33)作为白介素-1 (interleukin-1, IL-1)家族的细胞因子，其属于第11个炎症因子，同时也是辅助性T细胞2 (T helper cell 2, Th2)产生的炎性因子之一，IL-33作为一种前炎症细胞因子，通常在上皮细胞、内皮细胞和成纤维细胞中表达，当组织受到病原体攻击、感染或组织坏死时，通常与特异性受体生长刺激表达基因2蛋白(growth stimulation expressed gene 2, ST2)结合后激活细胞内相关信号通路，进而参与并调控先天性和获得性免疫反应，促进Th2型炎性细胞因子的表达，表现为相应的Th2型炎症状态。而慢性鼻窦炎伴鼻息肉(chronic rhinosinusitis with nasal polyps, CRSwNP)属于Th2型炎症疾病的代表之一，其炎症状态极为明显，因此，研究IL-33/ST2信号通路在慢性鼻窦炎伴鼻息肉中的作用对日后疾病的治疗具有重要意义。本文就IL-33/ST2信号通路在慢性鼻窦炎伴鼻息肉中的作用研究进展进行综述。
Abstract: As a cytokine of interleukin-1 (IL-1) family, interleukin-33 (IL-33) belongs to the 11th inflammatory cytokine and one of the inflammatory cytokines produced by Th2. As a pro-inflammatory cytokine, IL-33 is usually expressed in epithelial cells, endothelial cells and fibroblasts when tissues are at-tacked by pathogens, infected or necrotic. It is usually combined with the specific receptor growth stimulation expressed gene 2 (ST2) protein to activate intracellular related signaling pathways, and then participate in and regulate the innate and acquired immune responses, and promote the ex-pression of Th2-type inflammatory cytokines. It shows the corresponding Th2 inflammatory state. Chronic rhinosinusitis with nasal polyps (CRSwNP) is one of the representatives of Th2 inflammato-ry diseases, and the inflammatory state is more obvious. It is of great significance to study the role of IL-33/ST2 signaling pathway in the treatment of chronic rhinosinusitis with nasal polyps in the future. This article reviews the research progress of IL-33/ST2 signaling pathway in chronic rhi-nosinusitis with nasal polyps.
文章引用：李晨瑜, 袁芳. IL-33/ST2信号通路在慢性鼻窦炎伴鼻息肉中的作用研究进展[J]. 临床医学进展, 2022, 12(9): 8606-8613. https://doi.org/10.12677/ACM.2022.1291243

参考文献

[1] Baekkevold, E.S., Roussigné, M., Yamanaka, T., Johansen, F.E., Jahnsen, F.L., Amalric, F., Brandtzaeg, P., Erard, M., Haraldsen, G. and Girard, J.P. (2003) Molecular Characterization of NF-HEV, a Nuclear Factor Preferentially Expressed in Human High Endothelial Venules. The American Journal of Pathology, 163, 69-79. [Google Scholar] [CrossRef] 
[2] 刘果, 刘锋. IL-33/ST2信号通路在变应性鼻炎中的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(6): 565-568. [Google Scholar] [CrossRef] [PubMed]
[3] Ding, W., Zou, G.L., Zhang, W., Lai, X.N., Chen, H.W. and Xiong, L.X. (2018) Interleukin-33: Its Emerging Role in Allergic Diseases. Molecules, 23, Article No. 1665. [Google Scholar] [CrossRef] [PubMed]
[4] Ali, S., Mohs, A., Thomas, M., Klare, J., Ross, R., Schmitz, M.L. and Martin, M.U. (2011) The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB to Dampen NF-κB-Stimulated Gene Transcription. The Journal of Immunology, 187, 1609-1616. [Google Scholar] [CrossRef] [PubMed]
[5] Choi, Y.S., Park, J.A., Kim, J., Rho, S.S., Park, H., Kim, Y.M. and Kwon, Y.G. (2012) Nuclear IL-33 Is a Transcriptional Regulator of NF-κB p65 and Induces Endothelial Cell Activa-tion. Biochemical and Biophysical Research Communications, 421, 305-311. [Google Scholar] [CrossRef] [PubMed]
[6] Lüthi, A.U., Cullen, S.P., McNeela, E.A., Duriez, P.J., Afonina, I.S., Sheridan, C., et al. (2009) Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases. Immunity, 31, 84-98. [Google Scholar] [CrossRef] [PubMed]
[7] 彭海森, 朱新华. IL-33/ST2信号通路在变应性鼻炎发病机制中的研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(10): 910-914. [Google Scholar] [CrossRef] [PubMed]
[8] Cayrol, C. and Girard, J.P. (2014) IL-33: An Alarmin Cytokine with Crucial Roles in Innate Immunity, Inflammation and Allergy. Current Opinion in Immunology, 31, 31-37. [Google Scholar] [CrossRef] [PubMed]
[9] Molofsky, A.B., Savage, A.K. and Locksley, R.M. (2015) Interleu-kin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity, 42, 1005-1019. [Google Scholar] [CrossRef] [PubMed]
[10] Liew, F.Y., Girard, J.P. and Turnquist, H.R. (2016) Interleu-kin-33 in Health and Disease. Nature Reviews Immunology, 16, 676-689. [Google Scholar] [CrossRef] [PubMed]
[11] Saikumar Jayalatha, A.K., Hesse, L., Ketelaar, M.E., Koppelman, G.H. and Nawijn, M.C. (2021) The Central Role of IL-33/IL-1RL1 Pathway in Asthma: From Pathogenesis to Intervention. Pharmacology & Therapeutics, 225, Article ID: 107847. [Google Scholar] [CrossRef] [PubMed]
[12] Cayrol, C. and Girard, J.P. (2018) Interleukin-33 (IL-33): A Nuclear Cytokine from the IL-1 Family. Immunological Reviews, 281, 154-168. [Google Scholar] [CrossRef] [PubMed]
[13] alabot-Ayer, D., Lamacchia, C., Gabay, C. and Palmer, G. (2009) Interleu-kin-33 Is Biologically Activeindependently of Caspase-1 Cleavage. Journal of Biological Chemistry, 284, 19420-19426. [Google Scholar] [CrossRef] 
[14] Talabot-Ayer, D., Lamacchia, C., Gabay, C. and Palmer, G. (2009) Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage. J Biol Chem, 284, 19420-19426. [Google Scholar] [CrossRef] 
[15] Bulek, K., Swaidani, S., Qin, J., Lu, Y., Gulen, M.F., Herjan, T., Min, B., Kastelein, R.A., Aronica, M., Kosz- Vnenchak, M. and Li, X. (2009) The Essential Role of Single Ig IL-1 Re-ceptor-Related Molecule/Toll IL-1R8 in Regulation of Th2 Immune Response. The Journal of Immunology, 182, 2601-2609. [Google Scholar] [CrossRef] [PubMed]
[16] 杨钦泰, 孙悦奇, 吴庆武, 史剑波. 2020年欧洲鼻窦炎和鼻息肉意见书解读[J]. 中华耳鼻咽喉头颈外科杂志, 2020, 55(3): 304-308.
[17] 陈吉, 孙月, 高亚, 李脊, 杜进涛, 田金徽. 慢性鼻窦炎指南的评价与内容分析[J]. 中国全科医学, 2020, 23(13): 1583-1591.
[18] Rudmik, L. (2017) Economics of Chronic Rhinosinusitis. Current Allergy and Asthma Reports, 17, Article No. 20. [Google Scholar] [CrossRef] [PubMed]
[19] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018) [J].中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100.
[20] Kim, D.K., Jin, H.R., Eun, K.M., Mo, J.H., Cho, S.H., Oh, S., Cho, D. and Kim, D.W. (2017) The Role of Interleukin-33 in Chronic Rhinosinusitis. Thorax, 72, 635-645. [Google Scholar] [CrossRef] [PubMed]
[21] Ishinaga, H., Kitano, M., Toda, M., D’Alessandro-Gabazza, C.N., Gabazza, E.C., Shah, S.A. and Takeuchi, K. (2017) Interleukin-33 Induces Mucin Gene Expression and Goblet Cell Hyperplasia in Human Nasal Epithelial Cells. Cytokine, 90, 60-65. [Google Scholar] [CrossRef] [PubMed]
[22] 杨琳红, 董震, 王维峰. 缺氧因子在人鼻黏膜上皮细胞的表达研究[J]. 中国老年学杂志, 2008, 28(3): 255-257.
[23] Sun, M., He, C., Wu, W., Zhou, G., Liu, F., Cong, Y. and Liu, Z. (2017) Hypoxia inducible Factor-1α-Induced Interleukin-33 Expression in Intestinal Epithelia Contributes to mUcosal Homeostasis in Inflammatory Bowel Disease. Clinical and Experimental Immunology, 187, 428-440. [Google Scholar] [CrossRef] [PubMed]
[24] Huang, R., Mao, W., Wang, G., Ding, J., Sun, Y., Gao, G., Dong, P. and Sun, Z. (2020) Synergistic Relationship between TSLP and IL-33/ST2 Signaling Pathways in Allergic Rhinitis and the Effects of Hypoxia. International Forum of Allergy & Rhinology, 10, 511-520. [Google Scholar] [CrossRef] [PubMed]
[25] 廖波. TSLP, IL-33及其受体在嗜酸粒细胞性伴有鼻息肉的慢性鼻——鼻窦炎上皮细胞中的相互作用[D]: [博士学位论文]. 武汉: 华中科技大学, 2015.
[26] Lam, M., Hull, L., Imrie, A., Snidvongs, K., Chin, D., Pratt, E., Kalish, L., Sacks, R., Earls, P., Sewell, W., Harvey, R.J. (2015) Interleukin-25 and Interleukin-33 as Mediators of Eosinophilic Inflammation in Chronic Rhinosinusitis. American Journal of Rhinology & Allergy, 29, 175-181. [Google Scholar] [CrossRef] [PubMed]
[27] Song, W., Wang, C., Zhou, J., Pan, S. and Lin, S. (2017) IL-33 Expression in Chronic Rhinosinusitis with Nasal Polyps and Its Relationship with Clinical Severity. ORL, 79, 323-330. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, T., Lv, C. and Cao, Z. (2015) Expression and Role of IL-33 and Its Receptor ST2 in Eosinophilic and Non- Eosinophilic Chronic Rhinosinusitis with nasal Polyps. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 29, 1350-1353+1371. (In Chinese)
[29] Reh, D.D., Wang, Y., Ramanathan Jr., M. and Lane, A.P. (2010) Treatment-Recalcitrant Chronic Rhinosinusitis with Polyps Is Associated with Altered Epithelial Cell Expression of Interleukin-33. American Journal of Rhinology & Allergy, 24, 105-109. [Google Scholar] [CrossRef] [PubMed]
[30] Humphreys, N.E., Xu, D., Hepworth, M.R., Liew, F.Y. and Gren-cis, R.K. (2008) IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes. The Journal of Immunology, 180, 2443-2449. [Google Scholar] [CrossRef] [PubMed]
[31] Van Nevel, S., van Ovost, J., Holtappels, G., De Ruyck, N., Zhang, N., Braun, H., Maes, T., Bachert, C. and Krysko, O. (2021) Neutrophils Affect IL-33 Processing in Response to the Respiratory Allergen Alternaria alternata. Frontiers in Immunology, 12, Article ID: 677848. [Google Scholar] [CrossRef] [PubMed]
[32] Shaw, J.L., Fakhri, S., Citardi, M.J., Porter, P.C., Corry, D.B., Kheradmand, F., Liu, Y.J. and Luong, A. (2013) IL-33-Responsive Innate Lymphoid Cells Are an Important Source of IL-13 in Chronic Rhinosinusitis with Nasal Polyps. American Journal of Respiratory and Critical Care Medicine, 188, 432-439. [Google Scholar] [CrossRef] 
[33] Shaw, J.L., Ashoori, F., Fakhri, S., Citardi, M.J. and Luong, A. (2012) Increased Percentage of Mast Cells within Sinonasal Mucosa of Chronic Rhinosinusitis with Nasal Polyp Patients Independent of Atopy. International Forum of Allergy & Rhinology, 2, 233-240. [Google Scholar] [CrossRef] [PubMed]
[34] Gordon, E.D., Simpson, L.J., Rios, C.L., Ringel, L., Lachowicz-Scroggins, M.E., Peters, M.C., Wesolowska-Andersen, A., Gonzalez, J.R., MacLeod, H.J., Christian, L.S., Yuan, S., Barry, L., Woodruff, P.G., Ansel, K.M., Nocka, K., Seibold, M.A. and Fahy, J.V. (2016) Alternative Splicing of Interleukin-33 and Type 2 Inflammation in Asthma. Proceedings of the National Academy of Sciences of the United States of America, 113, 8765-8770. [Google Scholar] [CrossRef] [PubMed]

为你推荐